key: cord-1055046-gcog9wdq
authors: OULEGHZAL, Hassan; RAFAI, Mostafa; ELBENAYE, Jalal
title: Is there a Link between endocrine disruptors and COVID-19 severe pneumonia?
date: 2020-06-09
journal: Heart Lung
DOI: 10.1016/j.hrtlng.2020.06.002
sha: 61203fbebfa6bc7532d525757a5c5dbd65825212
doc_id: 1055046
cord_uid: gcog9wdq

nan

have fewer severe forms and fewer deaths despite the insufficient number of intensive care beds and respirators in these countries.

Endocrine disruptors act on target organs, especially the lungs, by acting on the immune and endocrine system.They are potential modulators of immune system homeostasis [1] .Therefore Endocrine disruptors can lead to abnormally more exaggerated inflammatory systemic immune responses and higher concentrations of cytokines during SARS-CoV-2.

Chinese studies support this hypothesis, they have shown that the cytokine profile of critically ill patients with COVID-19 is characterized by a cytokine storm and increased expression of interleukin (IL) -2R and IL-6 in serum [2] [3] [4] .

Endocrine disruptors also interfere with the metabolism of sex steroids, these affect and modulate immune function [5] . Severity of lung involvement during infection with COVID-19

is correlated with hyperandrogenemia [6] , who may be partly the result of the action of endocrine disruptors especially in elderly patients.

Studies are still required to clarify the role of endocrine disruptors in COVID-19 pneumonia and to establish a consensus in the future to reduce the duration to exposure to them and therefore limit their impacts.

A special issue on the environment and developmental origins of health and diseases

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Cytokine storm and immunomodulatory therapy in COVID-19:role of chloroquine and anti-IL-6 monoclonal antibodies

Steroid Hormones, Endocrine Disrupting Compounds and Immunotoxicology

SARS-COV-2 infection is likely to be androgenmediated